enGene
ENGN
NASDAQ
IPO2023
about ENGN
enGene is a biotechnology company focused on developing innovative gene therapy treatments and genetic engineering solutions to address serious diseases such as cancer, rare genetic disorders, and other life-threatening conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $8.55 | $11.14 | $7.83 | $307.66M | 50.06M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.57 | 5.04 | n/a | 0% | 0% | 16.88% |